Your browser doesn't support javascript.
loading
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Rowlands, Marianna; Segal, Florencia; Hartl, Dominik.
Affiliation
  • Rowlands M; Novartis Institutes for BioMedical Research (NIBR) Translational Medicine, Cambridge, MA, United States.
  • Segal F; Novartis Institutes for BioMedical Research (NIBR) Translational Medicine, Cambridge, MA, United States.
  • Hartl D; Novartis Institutes for BioMedical Research (NIBR), Translational Medicine, Basel, Switzerland.
Front Immunol ; 12: 697405, 2021.
Article in En | MEDLINE | ID: mdl-34220859
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Myeloid-Derived Suppressor Cells / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Myeloid-Derived Suppressor Cells / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Estados Unidos